Showing 1 - 13 results of 13 for search 'Yuankai Shi', query time: 0.12s
Refine Results
-
1
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI by Ning Lou, Ruyun Gao, Yuankai Shi, Xiaohong Han
Published 2024-12-01Get full text
Article -
2
-
3
-
4
-
5
-
6
Safety, pharmacokinetics, and efficacy of abexinostat, an novel histone deacetylase inhibitor, in Chinese patients with relapsed/refractory B cell non-Hodgkin lymphoma: a Phase 1 s... by Lin Gui, Zucheng Xie, Yan Qin, Peng Liu, Jianliang Yang, Xinrui Chen, Zhenyu Li, Ran Tao, Yuankai Shi
Published 2025-05-01Get full text
Article -
7
Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancer by Liling Huang, Haohua Zhu, Liyuan Dai, Yu Feng, Xinrui Chen, Zucheng Xie, Xingsheng Hu, Yutao Liu, Xuezhi Hao, Lin Lin, Hongyu Wang, Shengyu Zhou, Jiarui Yao, Le Tang, Xiaohong Han, Yuankai Shi
Published 2025-05-01Get full text
Article -
8
Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial... by Ying Cheng, Baohui Han, Kai Li, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Jing Zhu
Published 2020-04-01Get full text
Article -
9
Efficacy and Safety of Afatinib Plus Bevacizumab as First‐Line Treatment for Advanced NSCLC Patients With Epidermal Growth Factor Receptor (EGFR) Mutations: A Multicenter, Phase II... by Huiyang Shi, Miaohan Wang, Junling Li, Shi Jin, Minglei Zhuo, Jun Zhao, Hongxia Zhang, Meng Yang, Qingfang Shi, Haifeng Qin, Guilan Dong, Dongmei Lan, Zhong Dai, Yu Feng, Haohua Zhu, Jingyu Lu, Kai Zhu, Yuankai Shi, Xingsheng Hu
Published 2025-08-01Get full text
Article -
10
Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a multicentre, randomized, phase 3 study by Yuankai Shi, Xinshuai Wang, Zhidong Pei, Huaqiu Shi, Yanjun Zhang, Tienan Yi, Jiazhuan Mei, Yanzhen Guo, Youhong Dong, Tianjiang Ma, Qingyuan Zhang, Xiaojing Jia, Zhengqiu Zhu, Shen Xu, Yanyan Liu, Hongrui Niu, Weimei Jiang, Xiaodong Jiang, Shengyu Zhou, Li Sun
Published 2025-03-01Get full text
Article -
11
First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a rand... by Yuankai Shi, Yi Ba, Junye Wang, Jianping Xiong, Kangsheng Gu, Yigui Chen, Zhendong Zheng, Zishu Wang, Weijian Guo, Ying Cheng, Xianli Yin, Yunpeng Liu, Yuxian Bai, Enxiao Li, Qi Li, Liangjun Zhu, Wei Li, Da Jiang, Jingdong He, Jiansi Chen, Jianguo Sun, Sheng Hou
Published 2025-05-01Get full text
Article -
12
Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 study by Yuankai Shi, Qingyuan Zhang, Junsheng Wang, Zhong Ouyang, Tienan Yi, Jiazhuan Mei, Xinshuai Wang, Zhidong Pei, Tao Sun, Junheng Bai, Shundong Cang, Yarong Li, Guohong Fu, Tianjiang Ma, Huaqiu Shi, Jinping Liu, Xiaojia Wang, Hongrui Niu, Yanzhen Guo, Shengyu Zhou, Li Sun, Yanjie Yin
Published 2025-02-01Get full text
Article -
13
Efficacy and safety of bevacizumab biosimilar SIBP04 compared with bevacizumab (Avastin®) as first-line treatment for locally advanced or metastatic non-squamous non-small-cell lun... by Yuankai Shi, Minghong Bi, Qingshan Li, Guolei Wang, Jianhua Chen, Mingjun Li, Jianhua Shi, Jiazhuan Mei, Yinghua Ji, Qingdi Xia, Yuanqing Feng, Shufeng Xu, Tongmei Zhang, Xiaohui Gao, Shubin Tang, Jie Weng, Zhuo Cao, Hongbo Wu, Xiubao Ren, Hua Xie, Hua Liu, Qiang Liu, Xing Yin, Xiaoyong Luo, Jun Chen, Haiming Zhang, Zhiyuan Guo, Cuimin Ding, Xin Jin, Rongli Sun, Sheng Yang
Published 2025-07-01Get full text
Article